Catawba Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$307K	Hold	3,260	–	–	0.07%	168
2018 Q1	$264K	Sell	3,260 -40	-1%	-$3.43K	0.06%	180
2017 Q4	$294K	Sell	3,300 -670	-17%	-$58.3K	0.07%	175
2017 Q3	$369K	Sell	3,970 -345	-8%	-$30.5K	0.08%	167
2017 Q2	$392K	Buy	4,315 +160	+4%	+$14.6K	0.09%	164
2017 Q1	$365K	Hold	4,155	–	–	0.08%	186
2016 Q4	$344K	Buy	4,155 +715	+21%	+$61.5K	0.08%	184
2016 Q3	$318K	Buy	+3,440	New	+$324K	0.08%	186
2015 Q3	–	Sell	-2,040	Closed	-$279K	–	239
2015 Q2	$279K	Hold	2,040	–	–	0.07%	201
2015 Q1	$254K	Sell	2,040 -185	-8%	-$19.6K	0.06%	217
2014 Q4	$201K	Buy	+2,225	New	+$185K	0.05%	238